Anthropic's newsroom Jun-Sep 2026 carries no drug-candidate or trial announcement; its 27 Aug post says Claude models 'continue to block professional biology and drug development queries'. Product page names no candidates or pharma partners.
The clinical-trial market resolves YES only if a drug candidate publicly attributed to Claude Science is announced as entering a clinical trial on or before 31 August 2026; Anthropic's newsroom and the Claude Science product page are the source of truth.
AI has often sped up the early stages of drug discovery. It has not yet changed the fact that roughly nine in ten drugs fail in clinical trials. We looked at four big AI science efforts. The record of AI-made drugs is split: real scientific progress, and trials that stalled all the same.